| Literature DB >> 35889247 |
Arifa Sultana1, Md Jamal Hossain2, Md Ruhul Kuddus1, Mohammad A Rashid1, Miss Sharmin Zahan2, Saikat Mitra3, Arpita Roy4, Safaet Alam5, Md Moklesur Rahman Sarker2, Isa Naina Mohamed6.
Abstract
Medicinal plants have considerable potential as antimicrobial agents due to the presence of secondary metabolites. This comprehensive overview aims to summarize the classification, morphology, and ethnobotanical uses of Euphorbia neriifolia L. and its derived phytochemicals with the recent updates on the pharmacological properties against emerging infectious diseases, mainly focusing on bacterial, viral, fungal, and parasitic infections. The data were collected from electronic databases, including Google Scholar, PubMed, Semantic Scholar, ScienceDirect, and SpringerLink by utilizing several keywords like 'Euphorbia neriifolia', 'phytoconstituents', 'traditional uses', 'ethnopharmacological uses', 'infectious diseases', 'molecular mechanisms', 'COVID-19', 'bacterial infection', 'viral infection', etc. The results related to the antimicrobial actions of these plant extracts and their derived phytochemicals were carefully reviewed and summarized. Euphol, monohydroxy triterpene, nerifoliol, taraxerol, β-amyrin, glut-5-(10)-en-1-one, neriifolione, and cycloartenol are the leading secondary metabolites reported in phytochemical investigations. These chemicals have been shown to possess a wide spectrum of biological functions. Different extracts of E. neriifolia exerted antimicrobial activities against various pathogens to different extents. Moreover, major phytoconstituents present in this plant, such as quercetin, rutin, friedelin, taraxerol, epitaraxerol, taraxeryl acetate, 3β-friedelanol, 3β-acetoxy friedelane, 3β-simiarenol, afzelin, 24-methylene cycloarenol, ingenol triacetate, and β-amyrin, showed significant antimicrobial activities against various pathogens that are responsible for emerging infectious diseases. This plant and the phytoconstituents, such as flavonoids, monoterpenoids, diterpenoids, triterpenoids, and alkaloids, have been found to have significant antimicrobial properties. The current evidence suggests that they might be used as leads in the development of more effective drugs to treat emerging infectious diseases, including the 2019 coronavirus disease (COVID-19).Entities:
Keywords: Euphorbia neriifolia; ethnopharmacology; infectious diseases; molecular mechanisms; phytoconstituents; traditional applications
Mesh:
Substances:
Year: 2022 PMID: 35889247 PMCID: PMC9319654 DOI: 10.3390/molecules27144374
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Different parts (leaves, latex, fruits, and flowers) of the Euphorbia neriifolia plant.
Traditional uses of E. neriifolia.
| Disease | Traditional Background | Reference |
|---|---|---|
|
| ||
| Respiratory stimulant, arthritis, local anesthetic, paronychia, antibacterial, antiviral, and interferolick | Unani medicine | [ |
| Exerts “Katu” and “Tikta” action | Caraka Samhita | [ |
| Exerts “Virya” properties with “Usna” action | Susruta Samhita | [ |
| Gives “Guna”, “Vipaka”, and “Karma” properties | Vagbhata Geeta | [ |
| Deep cracks in feet soles | Used with castor oil by locals of Chhattisgarh | [ |
| Insecticide | Used as a spray by local farmers in India | [ |
| As a fence full of spines | Used by local farmers in India | [ |
| Allelopathic effect in weed control | Used by local farmers in India | [ |
|
| ||
| Used in aphrodisiac mixture | Chhattisgarh region of India | [ |
| Earache | Malay | [ |
| Obstinate skin disease, urinary disorders, and diabetes | Shusruta | [ |
| Coughs, skin problems | Used in Rajputana | [ |
| Piles | Used with turmeric in Indian medicine | [ |
| Ophthalmic use | Indian Medicine | [ |
| Cathartic, earache | Used by Indian Vaidya | [ |
| Whooping cough, leprosy, dyspepsia, jaundice, dropsy, colic, enlarged liver, and spleen | Used with salt by Indian Vaidya | [ |
| Removes warts | Used by Indian Vaidya | [ |
| External application for rheumatic limbs | Used with margosa oil or neem oil by Indian Vaidya | [ |
| Prevents the attack of red weevils in palms | Gujarat | [ |
| Anal fistulae | Indian medicine | [ |
| Asthma | Ayurveda | [ |
| Syphilis, visceral obstruction, spleen, and liver enlargement | Used with ghee in Rural area in India | [ |
|
| ||
| Ear problems | Sarawak | [ |
| Wound healing, CNS problems, and immunomodulatory effects | Used in Malaya | [ |
| Bronchitis, bleeding piles | Indian traditional medicine | [ |
| Earache | Used in Malaya and Philippines | [ |
| Wound-healing | The steamed leaves used in Indian medicine | [ |
| Respiratory trouble in children | Used with common salt an honey in localised areas in India | [ |
|
| ||
| Deroots skin warts | Indian traditional medicine | [ |
| Coughs and colds | Used with honey in Indian traditional medicine | [ |
| Chronic respiratory problems | Used with black pepper locally in India | [ |
| Promotes the expectoration of phlegm | Used with honey and borax by Indian Vaidya | [ |
| Hydrophobia | Used with fresh ginger by Indian Vaidya | [ |
|
| ||
| Antispasmodic activity | Used in Indian medicine | [ |
| Snake bites, scorpion stings | Used with black pepper in Indian medicine | [ |
| Dropsy | Used after boiling with rice water by Indian Vaidya | [ |
Figure 2Major characteristic phytoconstituents found in E. neriifolia.
Major compounds present in different parts of E. neriifolia and their antimicrobial activities.
| Name of the Compound | Structure | Plant Part | Pharmacological Activities | References | |||
|---|---|---|---|---|---|---|---|
| Antibacterial Activity | Antifungal Activity | Antiviral Activity | Antiparasitic Activity | ||||
| Quercetin |
| Leaves | Potent | - Inhibits C. albicans | - Inhibitory percentage is 82% at a 200 µM concentration | Exerts potential antiparasitic activities against Toxoplasma, | [ |
| Rutin |
| Leaves | Active against | - Inhibits | - Useful for treating retroviruses, herpes viruses, orthomyxoviruses, hepatitis B, and hepatitis C | Demonstrates | [ |
| 3β-friedelanol |
| Leaves | Not found | Not found | - Greater anti-HCoV activity than positive control actinomycin D with 132.4% survival rate | Not found | [ |
| 3β-acetoxy friedelane |
| Leaves | Not found | Not found | Anti-HCoV activity with 80.9% survival rate | Not found | [ |
| Friedelin |
| Leaves | Active against | Active against | Anti-HCoV activity with 80.9% survival rate | Not found | [ |
| Lupenone |
| Leaves | Not found | Not found | Against herpes simplex virus | Not found | [ |
| Epitaraxerol |
| Leaves | Inhibits | Inhibits | Anti-HCoV activity with 111.0% survival rate | Not found | [ |
| Epitaraxeryl acetate |
| Leaves | Not found | Not found | Antivirus activity against Epistein–Barr virus. | Not found | [ |
| Taraxeryl acetate |
| Leaves | MIC for | MIC for | Not found | Not found | [ |
| β-amyrin |
| Leaves | Contribute in the antibacterial | Inhibits the growth of | Inhibits Peste des Petits Ruminants virus. Exerts virucidal potential | Not found | [ |
| 3β-simiarenol |
| Leaves | Not found | Not found | Anti-HCoV activity | Not found | [ |
| Cycloartenol |
| Leaves, Roots, and Latex | Not found | Not found | Inhibits the migration of glioma cells and inhibits the phosphorylation of p38 MAP kinase. | Not found | [ |
| Cycloeucalenol |
| Leaves | Inhibits | Not found | Not found | Not found | [ |
| Afzelin |
| Leaves | Not found | Not found | Binds with the SARS-CoV 3CLpro protease and inhibits viral replication | Not found | [ |
| Euphonerin A |
| Leaves | Not found | Not found | Anti-HIV | Not found | [ |
| Euphonerin B |
| Leaves | Not found | Not found | Anti-HIV | Not found | [ |
| Euphonerin C |
| Leaves | Not found | Not found | Anti-HIV | Not found | [ |
| Euphonerin D |
| Leaves | Not found | Not found | Anti-HIV activity with EC50 of 34 µM | Not found | [ |
| Lectin | Latex | Active against | Active against | - Anti-HIV activity | Not found | [ | |
| Pachypodol (5,40-dihydroxy-3,7,30-trimethoxyflavone) |
| Leaves | Active against | Good activity against | Not found | Not found | [ |
| Taraxerol |
| Leaves and Stem | Exerted inhibition on | Not found | Antivirus activity against Epistein–Barr virus. | Not found | [ |
| 24-Methylenecycloarenol |
| Root and Bark | Not found | Not found | Interacts with binding site residues that are known to interfere with the activity of ACE2 in SARS-CoV-2 | Not found | [ |
| Ingenol triacetate |
| Root | Not found | Not found | Prevent HIV replication in MT-4 cells at 0.051–0.65 µM | Not found | [ |
| 12-Deoxyphorbol-13,20-diacetate |
| Root | Not found | Not found | Causes HIV-1 expression in latently infected T-cell and increases sensitivity to killing through immunotoxins. | Not found | [ |
| Tulipanin |
| Bark and Root | Active against | Not found | Not found | Not found | [ |
| n-hexacosanol | CH3(CH2)24CH2OH | Bark | Hexacosanol compounds exerted significant activities against | [ | |||
| Wax, Resin, Caoutchouc, Gum | Bark and Latex | Wax, resin, gum, and caoutchouc from different origins exert various pharmacological activities, including antibacterial, antifungal, antiviral, and antiparasitic activities | [ | ||||
Figure 3Antimicrobial activities of the major phytochemicals obtained from E. neriifolia.
Figure 4Possible antiviral activities of different constituents found in E. neriifolia to prevent COVID-19.
Figure 5Anti-inflammatory activity of Euphorbia neriifolia.